Clinic
Contra Costa County
Contra Costa County was paid $90.59M by Medicaid between Jan 2018 and Dec 2024, across 250 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 74% of everything it billed.
33Billing provider infoCONTRA COSTA COUNTY
MARTINEZ, CA 94553
MARTINEZ, CA 94553
33aNPI1942370762assigned 11/09/2006
33bProvider typeFederally Qualified Health Center (FQHC)
28Total paid$90.59M
24GClaims1,112,144
24DCodes billed250
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Federally Qualified Health Center (FQHC) providers in California
Rank by total paid#31 of 826
Median peer was paid$4.05M
This provider vs. median22×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LEE, DAVID controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 105,672 | $14.02M | |
| 2019 | 119,959 | $11.43M | |
| 2020 | 148,632 | $11.90M | |
| 2021 | 198,653 | $15.10M | |
| 2022 | 169,168 | $11.58M | |
| 2023 | 174,851 | $12.78M | |
| 2024incomplete | 195,209 | $13.80M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 74% | 199,141 | 178,399 | $67.45M |
| 0510 | 16% | 177,416 | 161,937 | $14.52M | |
| 00003 | Internal/system code - not a standard HCPCS code | 8.1% | 17,150 | 14,499 | $7.35M |
| G0467 | Community health center visit, returning patientFederally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | <1% | 3,017 | 2,778 | $581K |
| 99078 | <1% | 17,707 | 5,241 | $472K | |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | <1% | 3,445 | 671 | $73K |
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | <1% | 1,817 | 558 | $44K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | <1% | 983 | 288 | $27K |
| 0001A | <1% | 1,724 | 930 | $20K | |
| S0197 | Prenatal vitamins, 30-day supply | <1% | 1,880 | 1,757 | $16K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 408 | 91 | $10K |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | <1% | 403 | 108 | $9K |
238 more codes
| 0004A | <1% | 126 | $5K | |
| H1003 | Prenatal care, at-risk enhanced service; education | <1% | 185 | $2K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 16,463 | $2K |
| 0002A | <1% | 45 | $1K | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | <1% | 17 | $1K |
| Z7500 | <1% | 102,316 | $1K | |
| 97803 | <1% | 15 | $984.48 | |
| 0124A | <1% | 44 | $938.00 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 6,116 | $781.43 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 536 | $634.01 |
| 0064A | <1% | 15 | $600.00 | |
| 0054A | <1% | 13 | $520.00 | |
| 95910 | <1% | 3,896 | $439.95 | |
| 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | <1% | 284 | $351.25 |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 2,318 | $307.86 |
| 36415 | Collection of venous blood by venipuncture | <1% | 41,265 | $205.47 |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 647 | $202.55 |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 84,098 | $176.04 |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 41,316 | $164.08 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 15,437 | $148.59 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 10,773 | $125.69 |
| 84450 | <1% | 441 | $74.00 | |
| 84460 | <1% | 445 | $74.00 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 166 | $63.95 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,006 | $43.74 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,004 | $43.74 |
| 83013 | <1% | 131 | $43.50 | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 4,442 | $37.41 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,174 | $30.04 |
| Q3014 | Telehealth originating site facility fee | <1% | 34,158 | $24.65 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 937 | $15.13 |
| 86850 | <1% | 1,260 | $14.39 | |
| 87340 | <1% | 829 | $12.88 | |
| 86762 | <1% | 843 | $12.24 | |
| 86803 | <1% | 961 | $12.13 | |
| 86787 | <1% | 746 | $10.95 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,222 | $10.06 |
| 86592 | <1% | 980 | $5.32 | |
| 86900 | <1% | 1,260 | $3.71 | |
| 86901 | <1% | 1,260 | $3.71 | |
| 84703 | <1% | 50 | $3.41 | |
| 81001 | <1% | 187 | $2.68 | |
| 99242 | 0% | 318 | $0.00 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 10,828 | $0.00 |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 0% | 30,980 | $0.00 |
| 80061 | Lipid panel | 0% | 3,021 | $0.00 |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 0% | 7,834 | $0.00 |
| 92557 | 0% | 1,040 | $0.00 | |
| 81002 | 0% | 2,087 | $0.00 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 0% | 517 | $0.00 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 0% | 24,900 | $0.00 |
| 94060 | 0% | 1,659 | $0.00 | |
| 0272 | 0% | 8,964 | $0.00 | |
| 81510 | 0% | 276 | $0.00 | |
| Z6400 | 0% | 6,161 | $0.00 | |
| 92134 | 0% | 1,569 | $0.00 | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 0% | 605 | $0.00 |
| 83068 | 0% | 273 | $0.00 | |
| 95801 | 0% | 1,249 | $0.00 | |
| Z6300 | 0% | 1,849 | $0.00 | |
| 82465 | 0% | 742 | $0.00 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 548 | $0.00 |
| 99215 | Doctor's office visit, returning patient (complex) | 0% | 1,191 | $0.00 |
| 59425 | 0% | 155 | $0.00 | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 0% | 19,917 | $0.00 |
| C9257 | Injection, bevacizumab, 0.25 mg | 0% | 1,326 | $0.00 |
| 82274 | 0% | 1,543 | $0.00 | |
| 86200 | 0% | 94 | $0.00 | |
| 73610 | 0% | 1,255 | $0.00 | |
| Z6308 | 0% | 523 | $0.00 | |
| 99204 | Doctor's office visit, new patient (more involved) | 0% | 9,907 | $0.00 |
| 83721 | 0% | 2,300 | $0.00 | |
| 96417 | 0% | 180 | $0.00 | |
| 97810 | 0% | 5,172 | $0.00 | |
| 81025 | 0% | 441 | $0.00 | |
| Z6304 | 0% | 1,289 | $0.00 | |
| 86682 | 0% | 182 | $0.00 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 0% | 2,976 | $0.00 |
| 84155 | 0% | 236 | $0.00 | |
| 84165 | 0% | 236 | $0.00 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 898 | $0.00 |
| 80076 | 0% | 2,132 | $0.00 | |
| 67028 | Intravitreal injection of a pharmacologic agent | 0% | 2,302 | $0.00 |
| 81003 | 0% | 357 | $0.00 | |
| 83718 | 0% | 726 | $0.00 | |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | 0% | 799 | $0.00 |
| 82565 | 0% | 435 | $0.00 | |
| 84520 | 0% | 216 | $0.00 | |
| Z6200 | 0% | 1,966 | $0.00 | |
| 86480 | 0% | 62 | $0.00 | |
| 92083 | 0% | 547 | $0.00 | |
| J1756 | Injection, iron sucrose, 1 mg | 0% | 90 | $0.00 |
| 84425 | 0% | 244 | $0.00 | |
| 86359 | 0% | 236 | $0.00 | |
| 86146 | 0% | 43 | $0.00 | |
| 86708 | 0% | 60 | $0.00 | |
| Z6208 | 0% | 511 | $0.00 | |
| 59025 | Fetal non-stress test | 0% | 472 | $0.00 |
| 73630 | 0% | 226 | $0.00 | |
| 86038 | 0% | 339 | $0.00 | |
| Z6414 | 0% | 537 | $0.00 | |
| 92133 | 0% | 608 | $0.00 | |
| 99201 | 0% | 110 | $0.00 | |
| 82947 | 0% | 204 | $0.00 | |
| 84207 | 0% | 18 | $0.00 | |
| 94727 | 0% | 248 | $0.00 | |
| 11721 | 0% | 1,069 | $0.00 | |
| 73562 | 0% | 126 | $0.00 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 0% | 459 | $0.00 |
| 83540 | 0% | 221 | $0.00 | |
| 84439 | 0% | 200 | $0.00 | |
| 95816 | 0% | 64 | $0.00 | |
| 86431 | 0% | 272 | $0.00 | |
| V5060 | Hearing aid, monaural, behind the ear | 0% | 61 | $0.00 |
| 86360 | 0% | 123 | $0.00 | |
| 96523 | 0% | 191 | $0.00 | |
| 73100 | 0% | 72 | $0.00 | |
| Z7504 | 0% | 64 | $0.00 | |
| 96367 | 0% | 94 | $0.00 | |
| 90662 | 0% | 25 | $0.00 | |
| 83655 | 0% | 661 | $0.00 | |
| 94729 | 0% | 248 | $0.00 | |
| 95909 | 0% | 297 | $0.00 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 69 | $0.00 |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 0% | 188 | $0.00 |
| 85610 | 0% | 12 | $0.00 | |
| 81329 | 0% | 296 | $0.00 | |
| 86235 | 0% | 12 | $0.00 | |
| 99401 | 0% | 36 | $0.00 | |
| 84466 | 0% | 221 | $0.00 | |
| 86003 | 0% | 13 | $0.00 | |
| 76813 | 0% | 184 | $0.00 | |
| 84295 | 0% | 68 | $0.00 | |
| 80348 | 0% | 41 | $0.00 | |
| 11056 | 0% | 26 | $0.00 | |
| L0621 | Sacroiliac orthosis, flexible, provides pelvic-sacral support, reduces motion about the sacroiliac joint, includes straps, closures, may include pendulous abdomen design, prefabricated, off-the-shelf | 0% | 28 | $0.00 |
| 84630 | 0% | 16 | $0.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 27 | $0.00 |
| 86147 | 0% | 39 | $0.00 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 13 | $0.00 |
| 97161 | 0% | 12 | $0.00 | |
| 98940 | 0% | 190 | $0.00 | |
| 82310 | 0% | 25 | $0.00 | |
| 96402 | 0% | 18 | $0.00 | |
| 73110 | 0% | 135 | $0.00 | |
| 87338 | 0% | 12 | $0.00 | |
| 73130 | 0% | 78 | $0.00 | |
| 86039 | 0% | 14 | $0.00 | |
| 85613 | 0% | 16 | $0.00 | |
| 84100 | 0% | 18 | $0.00 | |
| 90686 | 0% | 787 | $0.00 | |
| Z6402 | 0% | 1,985 | $0.00 | |
| 85027 | 0% | 3,043 | $0.00 | |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 1,253 | $0.00 |
| 99024 | 0% | 3,924 | $0.00 | |
| Z6204 | 0% | 1,619 | $0.00 | |
| 86141 | 0% | 826 | $0.00 | |
| J3490 | Unclassified drugs | 0% | 22,597 | $0.00 |
| Z1034 | 0% | 2,311 | $0.00 | |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 2,962 | $0.00 |
| 82607 | 0% | 2,201 | $0.00 | |
| 85652 | 0% | 837 | $0.00 | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 0% | 1,981 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 3,923 | $0.00 |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 0% | 3,264 | $0.00 |
| 80053 | Comprehensive metabolic panel | 0% | 7,985 | $0.00 |
| 0271 | 0% | 1,218 | $0.00 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 6,062 | $0.00 |
| 88304 | 0% | 64 | $0.00 | |
| Z7610 | 0% | 9,746 | $0.00 | |
| 84132 | 0% | 80 | $0.00 | |
| 92567 | 0% | 1,136 | $0.00 | |
| 99241 | 0% | 478 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 3,153 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 2,594 | $0.00 |
| 0258 | 0% | 1,069 | $0.00 | |
| X7700 | 0% | 3,880 | $0.00 | |
| 20610 | 0% | 3,676 | $0.00 | |
| 84478 | 0% | 109 | $0.00 | |
| 86355 | 0% | 236 | $0.00 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 486 | $0.00 |
| 92002 | 0% | 835 | $0.00 | |
| Z6406 | 0% | 2,522 | $0.00 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 0% | 1,015 | $0.00 |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 0% | 336 | $0.00 |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 0% | 1,237 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 7,682 | $0.00 |
| 82670 | 0% | 289 | $0.00 | |
| 0700 | 0% | 745 | $0.00 | |
| 92250 | 0% | 1,696 | $0.00 | |
| 95911 | 0% | 2,535 | $0.00 | |
| 99205 | Prolong outpt/office vis | 0% | 1,684 | $0.00 |
| Q0164 | Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 141 | $0.00 |
| 82784 | 0% | 338 | $0.00 | |
| 99243 | 0% | 141 | $0.00 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 0% | 5,060 | $0.00 |
| 64615 | 0% | 2,493 | $0.00 | |
| 95860 | 0% | 608 | $0.00 | |
| 82550 | 0% | 792 | $0.00 | |
| 86364 | 0% | 284 | $0.00 | |
| 0636 | 0% | 44 | $0.00 | |
| 86706 | 0% | 96 | $0.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 423 | $0.00 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 0% | 148 | $0.00 |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 0% | 504 | $0.00 |
| 96415 | 0% | 902 | $0.00 | |
| 82728 | 0% | 225 | $0.00 | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 0% | 1,696 | $0.00 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 300 | $0.00 |
| 83921 | 0% | 105 | $0.00 | |
| 90656 | 0% | 318 | $0.00 | |
| 86225 | 0% | 67 | $0.00 | |
| 80051 | 0% | 42 | $0.00 | |
| Z6410 | 0% | 12 | $0.00 | |
| 86800 | 0% | 27 | $0.00 | |
| 86376 | 0% | 25 | $0.00 | |
| 86704 | 0% | 73 | $0.00 | |
| 82985 | 0% | 25 | $0.00 | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 0% | 340 | $0.00 |
| 83520 | 0% | 68 | $0.00 | |
| 97139 | 0% | 314 | $0.00 | |
| 86160 | 0% | 118 | $0.00 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 0% | 295 | $0.00 |
| 85730 | 0% | 16 | $0.00 | |
| 88142 | 0% | 12 | $0.00 | |
| 97750 | 0% | 81 | $0.00 | |
| 90688 | 0% | 16 | $0.00 | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 0% | 384 | $0.00 |
| 96375 | Therapeutic injection; each additional sequential IV push | 0% | 45 | $0.00 |
| 76820 | 0% | 93 | $0.00 | |
| Q5104 | Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 0% | 12 | $0.00 |
| 82746 | 0% | 13 | $0.00 | |
| 83519 | 0% | 13 | $0.00 | |
| 93280 | 0% | 20 | $0.00 | |
| 92136 | 0% | 15 | $0.00 | |
| 83993 | 0% | 12 | $0.00 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 13 | $0.00 |
| H2000 | Comprehensive multidisciplinary evaluation | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLEE, DAVID (DEPUTY CFO)
Parent organizationCONTRA COSTA COUNTY
| Provider | Location | Paid |
|---|---|---|
| Contra Costa County | Martinez, CA | $536.98M |
| Contra Costa County | Pittsburg, CA | $202.20M |
| Contra Costa County | San Pablo, CA | $170.81M |
| Contra Costa County | Martinez, CA | $100.64M |
| Contra Costa County | Concord, CA | $83.05M |
| Contra Costa County | Antioch, CA | $65.79M |
| Contra Costa County | Martinez, CA | $64.10M |
| Contra Costa County | Brentwood, CA | $45.11M |
| Contra Costa County | Concord, CA | $33.14M |
| Lone Star Ambulance 1, LLC | Corpus Christi, TX | $31.57M |
| Contra Costa County | Martinez, CA | $30.20M |
| Contra Costa County | San Pablo, CA | $28.69M |
| Contra Costa County | Pittsburg, CA | $24.26M |
| Contra Costa County | Concord, CA | $19.55M |
| Contra Costa County | Antioch, CA | $17.16M |
| Contra Costa County | Martinez, CA | $15.98M |
| Contra Costa County | North Richmond, CA | $14.20M |
| Contra Costa County | San Pablo, CA | $13.26M |
| Contra Costa County | Bay Point, CA | $10.44M |
| Contra Costa County | Martinez, CA | $7.24M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.